Filing Details
- Accession Number:
- 0001209191-19-045653
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-12 19:51:47
- Reporting Period:
- 2019-08-09
- Accepted Time:
- 2019-08-12 19:51:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645666 | Kezar Life Sciences Inc. | KZR | Pharmaceutical Preparations (2834) | 473366145 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744253 | J. Christopher Kirk | C/O Kezar Life Sciences, Inc. 4000 Shoreline Court, Suite 300 South San Francisco CA 94080 | President And Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-09 | 5,000 | $4.97 | 297,934 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.80 to $5.18 on August 9, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of issuer, full information regarding the number of shares purchased at each separate price.
- Total reflects 230 shares of common stock acquired on May 15, 2019 through the Company's 2018 Employee Stock Purchase Plan.
Billionaire Hedge Funds
